Mina John

739 total citations
29 papers, 526 citations indexed

About

Mina John is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Mina John has authored 29 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 9 papers in Virology and 9 papers in Epidemiology. Recurrent topics in Mina John's work include HIV Research and Treatment (9 papers), HIV/AIDS Research and Interventions (8 papers) and HIV/AIDS drug development and treatment (5 papers). Mina John is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS Research and Interventions (8 papers) and HIV/AIDS drug development and treatment (5 papers). Mina John collaborates with scholars based in Australia, United States and Barbados. Mina John's co-authors include Martyn A. French, James Flexman, Don Smith, Mark Bloch, Thomas A. Rasmussen, Edwina Wright, David Nolan, Silvana Gaudieri, Christine Bundell and Grace Thompson and has published in prestigious journals such as The Journal of Immunology, Science Advances and Frontiers in Microbiology.

In The Last Decade

Mina John

28 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mina John Australia	11	276	223	165	125	84	29	526
E. Mortier France	13	180 0.7×	236 1.1×	55 0.3×	139 1.1×	58 0.7×	37	534
Xien Gui China	15	346 1.3×	234 1.0×	165 1.0×	75 0.6×	47 0.6×	33	562
Giulia Tositti Italy	12	334 1.2×	166 0.7×	271 1.6×	64 0.5×	74 0.9×	28	607
G. Antonucci Italy	12	495 1.8×	294 1.3×	337 2.0×	106 0.8×	107 1.3×	36	655
Maximilian C. Aichelburg Austria	14	382 1.4×	250 1.1×	195 1.2×	43 0.3×	147 1.8×	32	533
V. Delcey France	14	385 1.4×	302 1.4×	57 0.3×	62 0.5×	261 3.1×	29	770
Hector Pérez Argentina	14	191 0.7×	227 1.0×	68 0.4×	178 1.4×	46 0.5×	56	501
Caroline Roussillon France	7	177 0.6×	149 0.7×	82 0.5×	65 0.5×	45 0.5×	12	381
Philippe de Saussure Switzerland	14	282 1.0×	109 0.5×	91 0.6×	85 0.7×	201 2.4×	22	584
J.‐J. Lefrère France	15	248 0.9×	228 1.0×	223 1.4×	76 0.6×	30 0.4×	46	715

Countries citing papers authored by Mina John

Since Specialization

Citations

This map shows the geographic impact of Mina John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mina John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mina John more than expected).

Fields of papers citing papers by Mina John

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mina John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mina John. The network helps show where Mina John may publish in the future.

Co-authorship network of co-authors of Mina John

This figure shows the co-authorship network connecting the top 25 collaborators of Mina John. A scholar is included among the top collaborators of Mina John based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mina John. Mina John is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crawford, K., Abha Chopra, Ramesh Ram, et al.. (2025). HIV-1 adapts to HLA class II–associated selection pressure exerted by CD4 ⁺ and CD8 ⁺ T cells. Science Advances. 11(7). eadr4238–eadr4238.

John, Mina, et al.. (2024). Real‐world use of long‐acting cabotegravir and rilpivirine: 12‐month results of the inJectable Antiretroviral therapy feasiBility Study (JABS). HIV Medicine. 25(8). 935–945. 15 indexed citations

Keane, Niamh M., Shay Leary, C. Almeida, et al.. (2022). Adaptation to HLA-associated immune pressure over the course of HIV infection and in circulating HIV-1 strains. PLoS Pathogens. 18(12). e1010965–e1010965. 5 indexed citations

Santis, Dianne De, Erika Della Mina, Sam Salman, et al.. (2022). A Novel Targeted Amplicon Next-Generation Sequencing Gene Panel for the Diagnosis of Common Variable Immunodeficiency Has a High Diagnostic Yield. Journal of Molecular Diagnostics. 24(6). 586–599. 6 indexed citations

Thompson, Grace, Peter Boan, Duncan Purtill, et al.. (2022). QuantiFERON‐cytomegalovirus to predict clinically significant cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Transplant Infectious Disease. 24(2). e13786–e13786. 6 indexed citations

Lim, Ee Mun, et al.. (2021). Calculated globulin as a screening tool for hypogammaglobulinaemia or paraproteins in hospitalized patients. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 58(3). 236–243. 9 indexed citations

D’Orsogna, Lloyd, C. Almeida, Yvonne M. Zoet, et al.. (2019). Drug-induced alloreactivity: A new paradigm for allorecognition. American Journal of Transplantation. 19(9). 2606–2613. 3 indexed citations

Giles, Michelle, Charlotte Bell, Catriona S. Bradshaw, et al.. (2019). The barriers to linkage and retention in care for women living with HIV in an high income setting where they comprise a minority group. AIDS Care. 31(6). 730–736. 8 indexed citations

Thompson, Grace, et al.. (2019). Autoantibodies in interstitial lung diseases. Pathology. 51(5). 518–523. 12 indexed citations

10.

Thompson, Grace, et al.. (2019). A breath of fresh air: investigating autoantibodies in interstitial lung disease. Pathology. 51. S132–S132. 1 indexed citations

11.

Thompson, Grace, Peter Boan, Jay Baumwol, et al.. (2018). Analysis of the QuantiFERON-CMV assay, CMV viraemia and antiviral treatment following solid organ transplantation in Western Australia. Pathology. 50(5). 554–561. 17 indexed citations

12.

Salman, Sam, et al.. (2018). IgE blockade in autoimmunity: Omalizumab induced remission of bullous pemphigoid. Clinical Immunology. 198. 54–56. 22 indexed citations

13.

Almeida, C., Yvonne M. Zoet, Abha Chopra, et al.. (2017). Stimulation of HIV-specific T cell clonotypes using allogeneic HLA. Cellular Immunology. 316. 32–40. 8 indexed citations

14.

Castley, Alison, et al.. (2015). Longitudinal Trends in Western Australian HIV-1 Sequence Diversity and Viral Transmission Networks and Their Influence on Clinical Parameters: 2000–2014. AIDS Research and Human Retroviruses. 32(3). 211–219. 5 indexed citations

15.

John, Mina & Silvana Gaudieri. (2014). Influence of HIV and HCV on T cell antigen presentation and challenges in the development of vaccines. Frontiers in Microbiology. 5. 514–514. 9 indexed citations

16.

John, Mina, et al.. (2013). Diagnostic dilemmas in celiac disease. Expert Review of Gastroenterology & Hepatology. 7(7). 643–655. 11 indexed citations

17.

Kumar, Alok & Mina John. (2002). Knowledge, Attitudes, and Sexual Practice Among the HIV Infected Women with Repeated Childbirths in Barbados. 4(2-3). 53–63. 1 indexed citations

18.

John, Mina, et al.. (2000). Nephrotic syndrome in a patient with IgA deficiency-associated mesangioproliferative glomerulonephritis. Pathology. 32(1). 56–58. 5 indexed citations

19.

John, Mina, James Flexman, & Martyn A. French. (1998). Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors. AIDS. 12(17). 2289–2293. 215 indexed citations

20.

John, Mina & Martyn A. French. (1998). Exacerbation of the inflammatory response toMycobacterium tuberculosisafter antiretroviral therapy. The Medical Journal of Australia. 169(9). 473–474. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact